DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Cantu MG, Buda A, Parma G. et al.
Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide, doxorubicin, and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens.
J Clin Oncol 2002; 20: 1232-1237
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.